Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Scherübl

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 14, 2021
[Type-2-diabetes and cancer risk]Hans Scherübl
Deutsche Medizinische Wochenschrift (1946)|September 28, 2019
[Alcohol Use and Cancer Risk]Hans Scherübl
The Lancet. Oncology|March 1, 2008
Options for gastroenteropancreatic neuroendocrine tumoursHans Scherübl
Pneumologie (Stuttgart, Germany)|January 24, 2023
[Tobacco smoking and cancer risk]Hans Scherübl
Archives of Surgery (Chicago, Ill. : 1960)|February 18, 2009
Local therapy of rectal carcinoids: a matter of debateHans Scherübl
The American Journal of Gastroenterology|September 17, 2022
Metabolic Syndrome and Estrogen Use Are Important Confounders in the Multifactorial Analysis of Colorectal Cancer RiskHans Scherübl
Deutsche Medizinische Wochenschrift (1946)|February 27, 2023
[Prevention of pancreatic cancer]Hans Scherübl
Zeitschrift Fur Gastroenterologie|November 15, 2022
[Metabolic syndrome and gastrointestinal cancer screening]Hans Scherübl
Zeitschrift Fur Gastroenterologie|October 12, 2023
[Early detection of sporadic pancreatic cancer]Hans Scherübl
Deutsche Medizinische Wochenschrift (1946)|August 15, 2022
[Metabolic syndrome and cancer risk]Hans Scherübl
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Deutsche Medizinische Wochenschrift (1946)|September 14, 2021
[Type-2-diabetes and cancer risk]Hans Scherübl
Deutsche Medizinische Wochenschrift (1946)|September 28, 2019
[Alcohol Use and Cancer Risk]Hans Scherübl
The Lancet. Oncology|March 1, 2008
Options for gastroenteropancreatic neuroendocrine tumoursHans Scherübl
Pneumologie (Stuttgart, Germany)|January 24, 2023
[Tobacco smoking and cancer risk]Hans Scherübl
Archives of Surgery (Chicago, Ill. : 1960)|February 18, 2009
Local therapy of rectal carcinoids: a matter of debateHans Scherübl
The American Journal of Gastroenterology|September 17, 2022
Metabolic Syndrome and Estrogen Use Are Important Confounders in the Multifactorial Analysis of Colorectal Cancer RiskHans Scherübl
Deutsche Medizinische Wochenschrift (1946)|February 27, 2023
[Prevention of pancreatic cancer]Hans Scherübl
Zeitschrift Fur Gastroenterologie|November 15, 2022
[Metabolic syndrome and gastrointestinal cancer screening]Hans Scherübl
Zeitschrift Fur Gastroenterologie|October 12, 2023
[Early detection of sporadic pancreatic cancer]Hans Scherübl
Deutsche Medizinische Wochenschrift (1946)|August 15, 2022
[Metabolic syndrome and cancer risk]Hans Scherübl
Pageof 9